Financials
Financial year 2025
VIVAPHARMA from Oudergem, company number BE0740481964, closed financial year 2025 with a result of € 118,241 after tax. For that financial year VIVAPHARMA recorded a gross margin of € 171,918 and equity of € 126,780. Compared with financial year 2024, the result moved from € 83,847 to € 118,241. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 8, 2026.
€ 126,780
▲ € 118,241 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 118,241
▲ 41% vs 2024
Profit after tax over the fiscal year.
€ 102,103
▲ 123% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 126,580.
Debts at end 2025
€ 61,276
▼ 20% vs 2024
€ 14,308 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.
€ 40,531
▲ 4% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 7,633
▼ 37% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 77,639 | € 56,668 | € 127,324 | € 171,918 | ▲ 35% |
| Profit after taxes | € -5,383 | € -10,309 | € 83,847 | € 118,241 | ▲ 41% |
| Equity | € -4,999 | € -15,308 | € 8,539 | € 126,780 | ▲ € 118,241 |
| Total debts | € 165,683 | € 147,094 | € 195,418 | € 109,516 | ▼ 44% |
| Cash | € 6,562 | € 2,406 | € 45,789 | € 102,103 | ▲ 123% |
| Retained profit | € -5,199 | € -15,508 | € 8,339 | € 126,580 | ▲ € 118,241 |
| Dividend | € 0 | € 0 | € 60,000 | € 0 | ▼ 100% |
| Bank debt | € 124,884 | € 101,171 | € 77,068 | € 61,276 | ▼ 20% |
| Balance sheet total | € 160,684 | € 131,786 | € 203,957 | € 236,296 | ▲ 16% |
Key figures of VIVAPHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to VIVAPHARMA?
What happened at VIVAPHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 118,241 (▲ 41% vs 2024). Source: NBB ↗
- New establishment in Oudergem. KBO
- Incorporation, published in the Gazette. Source: Staatsblad ↗
In short
From € 5,383 loss in 2022 to € 118,241 profit in 2025.
Paid € 65,323 in corporate taxes since 2022.
Best year ever: 2025, with € 118,241 profit.
Paid out € 60,000 in dividends to the owners in total.
Management
Behind VIVAPHARMA is ERYA PHARMA SRL.
Directors
According to the 2025 annual accounts
Director · represented by EYA TURKI
Establishments
Establishment units
Physical locations of this company
Waverse steenweg 1585
1160 Oudergem
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- MAMAGHANI Nina(oprichter) 50%
- GYSEMBERG Sophie Julie Francine(oprichter) 50%
Details
- Company number
- 0740.481.964
- VAT number
- BE 0740.481.964
- Registered office
- Waverse steenweg 1585, 1160 Oudergem
- Names & denominations
- VIVAPHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 26 December 2019
- Peppol
- Active · Active since 15 Jan 2026
- Activities · NACE
Detailhandel in farmaceutische producten
Overige detailhandel in voedingsmiddelen, neg
Detailhandel in cosmetica en toiletartikelen
Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen
Overige detailhandel in voedingsmiddelen in gespecialiseerde winkels, n.e.g.
Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels